For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.
Pathology & Laboratory Medicine

You are here

News

Hidden Code Activates Genes That Rapidly Respond to Pathogen Threats

A code discovered in DNA packaging proteins enables the rapid expression of genes needed to fight immediate threats, a finding that may pave the way for new treatments for cancer and inflammatory diseases, according to a study by investigators at Weill Cornell Medicine.

A study published in Nature on July 22 found that when a chemical tag composed of a phosphate group is added to H3.3, one of the spool-like histone proteins that condense DNA and control access to genes, the cell’s gene expression machinery can quickly find the genes.

A man posing for a photo

Dr. Steven Josefowicz
Assistant Professor of Pathology and Laboratory Medicine

“The phosphate-tagged H3.3 histone flags the rapid-response genes,” said Dr. Steven Josefowicz, an assistant professor of pathology and laboratory medicine at Weill Cornell Medicine. “It brings the machinery necessary for gene expression to that part of the genome and prioritizes the expression of the genes needed to fight the pathogen.”

Scientists have long known that cells can activate a small set of “rapid-response” genes to fight immediate threats like pathogens. But with so many genes stored in such a tiny package (the micron-scale nucleus), researchers have sought how signals can turn on select genes quickly and to high levels. Dr. Josefowicz’s team and collaborators had a hunch that a hidden code in histones played a key role in rapid gene expression.

That hunch proved correct when they discovered that immune cell exposure to a pathogen led to a chemical change in those cells’ histones, and only at the genes that are turned on rapidly after a stimulus. That chemical change was the addition of a phosphate group to H3.3 histones, in a process known as phosphorylation.

CAP Today Interview with Dr. Alain C. Borczuk

Don't miss the front page CAP Today interview with Alain C. Borczuk, M.D., Chief of Thoracic Pathology at Weill Cornell Medicine, on his work to understand lung injury patterns in COVID-19 patients.

Read the full article here.

Dr. Domenick Falcone Appointed Assistant Dean for Foundation Curriculum

Domenick Falcone, PhD
Professor of Pathology and Laboratory Medicine

Please join us in congratulating Domenick Falcone, PhD on becoming the inaugural Assistant Dean for Foundation Curriculum.

Dr. Domenick Falcone, Professor of Pathology and Laboratory Medicine and currently Co-Director of the first-year foundational Essential Principles of Medicine (EPOM) course and Leader of the Injury, Infection, Immunity and Repair unit of EPOM, will become the inaugural Assistant Dean for Foundational Curriculum. Dr. Falcone has shown true dedication and innovation in medical education for nearly forty years. He has been a key contributor to curricular design and reform, and he has consistently taught in the foundational curriculum where he has received many honors recognizing his exceptional teaching skills and leadership in medical education. He has also been the holder of Education Scholar Awards, including the Thomas H. Meikle Chair of Medical Education and the Gary M. Sumers Educational Scholar Award. 

So proud to have him on our faculty!!!

Weill Cornell Medicine Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464 Fax: (212) 746-8192